Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.2 USD | -1.22% |
|
+3.35% | +56.20% |
16/07 | Truist Raises Price Target on Glaukos to $141 From $125, Maintains Buy Rating | MT |
15/07 | Morgan Stanley Raises Price Target on Glaukos to $120 From $100, Keeps Equalweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.20% | 6.86B | |
+11.75% | 127B | |
+0.97% | 12B | |
-18.47% | 6.88B | |
+9.27% | 3.47B | |
-15.41% | 2.54B | |
-18.25% | 1.9B | |
-27.00% | 1.58B | |
-37.52% | 1.43B | |
-14.29% | 1.08B |
- Stock Market
- Equities
- GKOS Stock
- News Glaukos Corporation
- Transcript : Glaukos Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 05